AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
SELECTIVE-INHIBITION OF CELL-PROLIFERATION AND BCR-ABL PHOSPHORYLATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS EXPRESSING M-R-190,000 BCR-ABLPROTEIN BY A TYROSINE KINASE INHIBITOR (CGP-57148)
Authors: BERAN M CAO XB ESTROV Z JEHA S JIN GZ OBRIEN S TALPAZ M ARLINGHAUS RB LYDON NB KANTARJIAN H
Citation: M. Beran et al., SELECTIVE-INHIBITION OF CELL-PROLIFERATION AND BCR-ABL PHOSPHORYLATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS EXPRESSING M-R-190,000 BCR-ABLPROTEIN BY A TYROSINE KINASE INHIBITOR (CGP-57148), Clinical cancer research, 4(7), 1998, pp. 1661-1672
INHIBITION OF EPIDERMAL GROWTH FACTOR-MEDIATED ERK1 2 ACTIVATION BY IN-SITU ELECTROPORATION OF NONPERMEANT [(ALKYLAMINO)METHYL]ACRYLOPHENONE DERIVATIVES/
Authors: BROWNELL HL LYDON NB SCHAEFER E ROBERTS TM RAPTIS L
Citation: Hl. Brownell et al., INHIBITION OF EPIDERMAL GROWTH FACTOR-MEDIATED ERK1 2 ACTIVATION BY IN-SITU ELECTROPORATION OF NONPERMEANT [(ALKYLAMINO)METHYL]ACRYLOPHENONE DERIVATIVES/, DNA and cell biology, 17(3), 1998, pp. 265-274
SELECTIVE-INHIBITION OF THE PLATELET-DERIVED GROWTH-FACTOR SIGNAL-TRANSDUCTION PATHWAY BY A PROTEIN-TYROSINE KINASE INHIBITOR OF THE 2-PHENYLAMINOPYRIMIDINE CLASS (VOL 92, PG 2558, 1995)
Authors: BUCHDUNGER E ZIMMERMANN J METT H MEYER T MULLER M REGENASS U LYDON NB
Citation: E. Buchdunger et al., SELECTIVE-INHIBITION OF THE PLATELET-DERIVED GROWTH-FACTOR SIGNAL-TRANSDUCTION PATHWAY BY A PROTEIN-TYROSINE KINASE INHIBITOR OF THE 2-PHENYLAMINOPYRIMIDINE CLASS (VOL 92, PG 2558, 1995), Proceedings of the National Academy of Sciences of the United Statesof America, 95(20), 1998, pp. 12069-12069
4,5-DIANILINOPHTHALIMIDE - A PROTEIN-TYROSINE KINASE INHIBITOR WITH SELECTIVITY FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR SIGNAL-TRANSDUCTION PATHWAY AND POTENT IN-VIVO ANTITUMOR-ACTIVITY (VOL 91, PG 2334, 1994)
Authors: BUCHDUNGER E TRINKS U METT H REGENASS U MULLER M MEYER T MCGLYNN E PINNA LA TRAXLER P LYDON NB
Citation: E. Buchdunger et al., 4,5-DIANILINOPHTHALIMIDE - A PROTEIN-TYROSINE KINASE INHIBITOR WITH SELECTIVITY FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR SIGNAL-TRANSDUCTION PATHWAY AND POTENT IN-VIVO ANTITUMOR-ACTIVITY (VOL 91, PG 2334, 1994), Proceedings of the National Academy of Sciences of the United Statesof America, 95(20), 1998, pp. 12069-12069
A POTENT PROTEIN-TYROSINE KINASE INHIBITOR WHICH SELECTIVELY BLOCKS PROLIFERATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR-EXPRESSING TUMOR-CELLS IN-VITRO AND IN-VIVO
Authors: LYDON NB METT H MUELLER M BECKER M COZENS RM STOVER D DANIELS D TRAXLER P BUCHDUNGER E
Citation: Nb. Lydon et al., A POTENT PROTEIN-TYROSINE KINASE INHIBITOR WHICH SELECTIVELY BLOCKS PROLIFERATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR-EXPRESSING TUMOR-CELLS IN-VITRO AND IN-VIVO, International journal of cancer, 76(1), 1998, pp. 154-163
INHIBITION OF THE ABL KINASE-ACTIVITY BLOCKS THE PROLIFERATION OF BCRABL(+) LEUKEMIC-CELLS AND INDUCES APOPTOSIS/
Authors: GAMBACORTIPASSERINI C LECOUTRE P MOLOGNI L FANELLI M BERTAZZOLI C MARCHESI E DINICOLA M BIONDI A CORNEO GM BELOTTI D POGLIANI E LYDON NB
Citation: C. Gambacortipasserini et al., INHIBITION OF THE ABL KINASE-ACTIVITY BLOCKS THE PROLIFERATION OF BCRABL(+) LEUKEMIC-CELLS AND INDUCES APOPTOSIS/, Blood cells, molecules, & diseases, 23(19), 1997, pp. 380-394
STRUCTURES OF STAUROSPORINE BOUND TO CDK2 AND CAPK - NEW TOOLS FOR STRUCTURE-BASED DESIGN OF PROTEIN-KINASE INHIBITORS
Authors: TOLEDO LM LYDON NB
Citation: Lm. Toledo et Nb. Lydon, STRUCTURES OF STAUROSPORINE BOUND TO CDK2 AND CAPK - NEW TOOLS FOR STRUCTURE-BASED DESIGN OF PROTEIN-KINASE INHIBITORS, Structure, 5(12), 1997, pp. 1551-1556
POTENT AND SELECTIVE INHIBITORS OF THE ABL-KINASE - PHENYLAMINO-PYRIMIDINE (PAP) DERIVATIVES
Authors: ZIMMERMANN J BUCHDUNGER E METT H MEYER T LYDON NB
Citation: J. Zimmermann et al., POTENT AND SELECTIVE INHIBITORS OF THE ABL-KINASE - PHENYLAMINO-PYRIMIDINE (PAP) DERIVATIVES, Bioorganic & medicinal chemistry letters, 7(2), 1997, pp. 187-192
CGP-57148, A TYROSINE KINASE INHIBITOR, INHIBITS THE GROWTH OF CELLS EXPRESSING BCR-ABL, TEL-ABL, AND TEL-PDGFR FUSION PROTEINS
Authors: CARROLL M OHNOJONES S TAMURA S BUCHDUNGER E ZIMMERMANN J LYDON NB GILLILAND DG DRUKER BJ
Citation: M. Carroll et al., CGP-57148, A TYROSINE KINASE INHIBITOR, INHIBITS THE GROWTH OF CELLS EXPRESSING BCR-ABL, TEL-ABL, AND TEL-PDGFR FUSION PROTEINS, Blood, 90(12), 1997, pp. 4947-4952
CGP 57148, A TYROSINE KINASE INHIBITOR, INHIBITS THE GROWTH OF CELLS EXPRESSING BCR-ABL, TEL-ABL, AND TEL-PDGFR FUSION PROTEINS
Authors: DRUKER BJ CARROLL M OHNOJONES S TAMURA S BUCHDUNGER E LYDON NB GILLILAND DG
Citation: Bj. Druker et al., CGP 57148, A TYROSINE KINASE INHIBITOR, INHIBITS THE GROWTH OF CELLS EXPRESSING BCR-ABL, TEL-ABL, AND TEL-PDGFR FUSION PROTEINS, Blood, 90(10), 1997, pp. 1091-1091
EFFECTS OF A SELECTIVE INHIBITOR OF THE ABL TYROSINE KINASE ON THE GROWTH OF BCR-ABL POSITIVE CELLS
Authors: DRUKER BJ TAMURA S BUCHDUNGER E OHNO S SEGAL GM FANNING S ZIMMERMANN J LYDON NB
Citation: Bj. Druker et al., EFFECTS OF A SELECTIVE INHIBITOR OF THE ABL TYROSINE KINASE ON THE GROWTH OF BCR-ABL POSITIVE CELLS, Nature medicine, 2(5), 1996, pp. 561-566
PHENYLAMINO-PYRIMIDINE (PAP) - DERIVATIVES - A NEW CLASS OF POTENT AND HIGHLY SELECTIVE PDGF-RECEPTOR AUTOPHOSPHORYLATION INHIBITORS
Authors: ZIMMERMANN J BUCHDUNGER E METT H MEYER T LYDON NB TRAXLER P
Citation: J. Zimmermann et al., PHENYLAMINO-PYRIMIDINE (PAP) - DERIVATIVES - A NEW CLASS OF POTENT AND HIGHLY SELECTIVE PDGF-RECEPTOR AUTOPHOSPHORYLATION INHIBITORS, Bioorganic & medicinal chemistry letters, 6(11), 1996, pp. 1221-1226
PHENYLAMINO-PYRIMIDINE (PAP) DERIVATIVES - A NEW CLASS OF POTENT AND SELECTIVE INHIBITORS OF PROTEIN-KINASE-C (PKC)
Authors: ZIMMERMANN J CARAVATTI G METT H MEYER T MULLER M LYDON NB FABBRO D
Citation: J. Zimmermann et al., PHENYLAMINO-PYRIMIDINE (PAP) DERIVATIVES - A NEW CLASS OF POTENT AND SELECTIVE INHIBITORS OF PROTEIN-KINASE-C (PKC), Archiv der pharmazie, 329(7), 1996, pp. 371-376
MODULATION OF THE SH2 BINDING-SPECIFICITY AND KINASE-ACTIVITY OF SRC BY TYROSINE PHOSPHORYLATION WITHIN ITS SH2 DOMAIN
Authors: STOVER DR FURET P LYDON NB
Citation: Dr. Stover et al., MODULATION OF THE SH2 BINDING-SPECIFICITY AND KINASE-ACTIVITY OF SRC BY TYROSINE PHOSPHORYLATION WITHIN ITS SH2 DOMAIN, The Journal of biological chemistry, 271(21), 1996, pp. 12481-12487
A STRATEGY FOR SCREENING ANTITUMOR DRUGS UTILIZING ONCOGENES ENCODED IN RETROVIRAL VECTORS
Authors: CORBLEY MJ CHERINGTON V TRAXLER PM LYDON NB ROBERTS TM
Citation: Mj. Corbley et al., A STRATEGY FOR SCREENING ANTITUMOR DRUGS UTILIZING ONCOGENES ENCODED IN RETROVIRAL VECTORS, International journal of cancer, 66(6), 1996, pp. 753-759
INHIBITION OF THE ABL PROTEIN-TYROSINE KINASE IN-VITRO AND IN-VIVO BYA 2-PHENYLAMINOPYRIMIDINE DERIVATIVE
Authors: BUCHDUNGER E ZIMMERMANN J METT H MEYER T MULLER M DRUKER BJ LYDON NB
Citation: E. Buchdunger et al., INHIBITION OF THE ABL PROTEIN-TYROSINE KINASE IN-VITRO AND IN-VIVO BYA 2-PHENYLAMINOPYRIMIDINE DERIVATIVE, Cancer research, 56(1), 1996, pp. 100-104
INHIBITION OF THE ABELSON KINASE-ACTIVITY SELECTIVELY BLOCKS THE GROWTH OF BCR ABL LEUKEMIC-CELLS/
Authors: GAMBACORTIPASSERINI C MARCHESI E MOLOGNI L BERTAZZOLI C LECOUTRE P BIONDI A CORNCO GM POGLIANI E LYDON NB
Citation: C. Gambacortipasserini et al., INHIBITION OF THE ABELSON KINASE-ACTIVITY SELECTIVELY BLOCKS THE GROWTH OF BCR ABL LEUKEMIC-CELLS/, Blood, 88(10), 1996, pp. 924-924
THE TYROSINE KINASE INHIBITOR CGP-57148 SELECTIVELY INHIBITS HEMATOPOIETIC COLONY FORMATION BY CML PROGENITOR CELLS OVER A 2-LOG DOSE RANGE
Authors: DEININGER M GOLDMAN JM LYDON NB MELO JV
Citation: M. Deininger et al., THE TYROSINE KINASE INHIBITOR CGP-57148 SELECTIVELY INHIBITS HEMATOPOIETIC COLONY FORMATION BY CML PROGENITOR CELLS OVER A 2-LOG DOSE RANGE, Blood, 88(10), 1996, pp. 1444-1444
BCR-ABL POSITIVE CELL-LINES SHOW DIFFERENTIAL SENSITIVITY TO THE EFFECTS OF THE TYROSINE KINASE INHIBITOR CGP-57148
Authors: DEININGER M GOLDMAN JM LYDON NB MELO JV
Citation: M. Deininger et al., BCR-ABL POSITIVE CELL-LINES SHOW DIFFERENTIAL SENSITIVITY TO THE EFFECTS OF THE TYROSINE KINASE INHIBITOR CGP-57148, Blood, 88(10), 1996, pp. 1445-1445
4,5-BIS(4-FLUOROANILINO)PHTHALIMIDE - A SELECTIVE INHIBITOR OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR SIGNAL-TRANSDUCTION PATHWAY WITH POTENTIN-VIVO ANTITUMOR-ACTIVITY
Authors: BUCHDUNGER E METT H TRINKS U REGENASS U MULLER M MEYER T BEILSTEIN P WIRZ B SCHNEIDER P TRAXLER P LYDON NB
Citation: E. Buchdunger et al., 4,5-BIS(4-FLUOROANILINO)PHTHALIMIDE - A SELECTIVE INHIBITOR OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR SIGNAL-TRANSDUCTION PATHWAY WITH POTENTIN-VIVO ANTITUMOR-ACTIVITY, Clinical cancer research, 1(8), 1995, pp. 813-821
INTERACTION OF SRC WITH RECEPTOR TYROSINE KINASES
Authors: STOVER DR LYDON NB
Citation: Dr. Stover et Nb. Lydon, INTERACTION OF SRC WITH RECEPTOR TYROSINE KINASES, Journal of cellular biochemistry, 1995, pp. 44-44
SELECTIVE-INHIBITION OF THE PLATELET-DERIVED GROWTH-FACTOR SIGNAL-TRANSDUCTION PATHWAY BY A NOVEL TYROSINE PROTEIN-KINASE INHIBITOR OF THE 2-PHENYLAMINO PYRIMIDINE CLASS
Authors: LYDON NB ZIMMERMANN J METT H MEYER T MULLER M REGENASS U BUCHDUNGER E
Citation: Nb. Lydon et al., SELECTIVE-INHIBITION OF THE PLATELET-DERIVED GROWTH-FACTOR SIGNAL-TRANSDUCTION PATHWAY BY A NOVEL TYROSINE PROTEIN-KINASE INHIBITOR OF THE 2-PHENYLAMINO PYRIMIDINE CLASS, Journal of cellular biochemistry, 1995, pp. 69-69
SELECTIVE-INHIBITION OF THE PLATELET-DERIVED GROWTH-FACTOR SIGNAL-TRANSDUCTION PATHWAY BY A PROTEIN-TYROSINE KINASE INHIBITOR OF THE 2-PHENYLAMINOPYRIMIDINE CLASS
Authors: BUCHDUNGER E ZIMMERMANN J METT H MEYER T MULLER M REGENASS U LYDON NB
Citation: E. Buchdunger et al., SELECTIVE-INHIBITION OF THE PLATELET-DERIVED GROWTH-FACTOR SIGNAL-TRANSDUCTION PATHWAY BY A PROTEIN-TYROSINE KINASE INHIBITOR OF THE 2-PHENYLAMINOPYRIMIDINE CLASS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(7), 1995, pp. 2558-2562
INHIBITION OF EPIDERMAL GROWTH-FACTOR RECEPTOR PROTEIN-TYROSINE KINASE - A POTENTIAL TREATMENT FOR PSORIASIS
Authors: WRIGHT JD KEMP DM LYDON NB BLUM W TRAXLER P WOOLLEY A TAYLOR PW
Citation: Jd. Wright et al., INHIBITION OF EPIDERMAL GROWTH-FACTOR RECEPTOR PROTEIN-TYROSINE KINASE - A POTENTIAL TREATMENT FOR PSORIASIS, Journal of investigative dermatology, 105(3), 1995, pp. 487-487
SRC PHOSPHORYLATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AT NOVEL SITES MEDIATES RECEPTOR INTERACTION WITH SRC AND P85-ALPHA
Authors: STOVER DR BECKER M LIEBETANZ J LYDON NB
Citation: Dr. Stover et al., SRC PHOSPHORYLATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AT NOVEL SITES MEDIATES RECEPTOR INTERACTION WITH SRC AND P85-ALPHA, The Journal of biological chemistry, 270(26), 1995, pp. 15591-15597
Risultati: 1-25 | 26-29